Active — Not RecruitingNot Applicable

Guaranteed Income and Financial Treatment

United States250 participantsStarted 2023-04-01

Plain-language summary

The goal of this clinical trial is to learn if providing advanced cancer patients with $1000/month for 12 months will improve cancer outcomes. The main questions it aims to answer are: To what extent does receiving $1000/month additional income reduce financial hardship? To what extent does receiving $1000/month additional income improve quality of life? Does receiving $1000/month additional income improve survival outcomes? Participants will: Receive $1000/month for 12 months Complete a survey every 3 months for 12 months If selected, participate in semi-structured interviews about their financial behaviors

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age = 18 or older
✓. Newly diagnosed or recurrent advanced cancer (Stage 3 or 4)
✓. Receiving chemotherapy or immunotherapy (with or without radiation) at one of the recruitment sites
✓. Within 12 months of receiving systemic therapy and on surveillance at one of the recruitment sites
✓. ECOG performance status of 1 - 2
✓. A Pennsylvania Medicaid beneficiary
✓. A Pennsylvania resident

Exclusion criteria

✕. Eligible for hospice (i.e. determined by provider to have a prognosis of 6 months or less) at time of randomization
✕. Unable to communicate in English, Spanish, or Mandarin

What they're measuring

Financial Toxicity

Timeframe: 6 and 12 months from enrollment

Treatment adherence

Timeframe: 6 and 12 months from enrollment

Trial details

NCT IDNCT06611982

SponsorMeredith Doherty, PhD, LCSW

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-30

View on ClinicalTrials.gov More Cancer trials